PTC Therapeutics (NasdaqGS:PTCT) FY Conference Transcript

PTC Therapeutics (NasdaqGS:PTCT) FY Conference March 02, 2026 09:50 AM ET Company ParticipantsJoseph Thome - Managing Director of Biotechnology Equity ResearchMatthew Klein - President and CEOPierre Gravier - CFOJoseph ThomeAll right, I think we're gonna go ahead and get started. Thank you everyone for joining us in the room and online today at TD Cowen's 2026 Healthcare Conference. I'm Joseph Thome, one of the senior biotech analysts here on the team at TD Cowen. It is my pleasure to have with me this morn ...